Humacyte Inc (HUMA)
7.20
+0.14
(+1.98%)
USD |
NASDAQ |
May 21, 15:12
Humacyte Cash from Investing (Quarterly): -0.391M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.391M |
| December 31, 2023 | -0.15M |
| September 30, 2023 | -0.493M |
| June 30, 2023 | 1.622M |
| March 31, 2023 | -1.152M |
| December 31, 2022 | 5.212M |
| September 30, 2022 | -0.211M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.134M |
| March 31, 2022 | -0.022M |
| December 31, 2021 | -8.045M |
| September 30, 2021 | -0.083M |
| June 30, 2021 | -0.063M |
| March 31, 2021 | -0.029M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.045M
Minimum
Dec 2021
5.212M
Maximum
Dec 2022
-0.303M
Average
-0.134M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -0.029M |
| Adial Pharmaceuticals Inc | -- |
| Gritstone Bio Inc | 12.30M |
| Precision BioSciences Inc | -0.026M |
| Puma Biotechnology Inc | -19.08M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.35M |
| Cash from Financing (Quarterly) | 62.80M |
| Free Cash Flow | -83.53M |
| Free Cash Flow Per Share (Quarterly) | -0.2563 |
| Free Cash Flow Yield | -11.08% |